Schonfeld Strategic Advisors LLC Cytokinetics Inc Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 15,699 shares of CYTK stock, worth $862,503. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,699
Previous 39,614
60.37%
Holding current value
$862,503
Previous $2.78 Million
69.39%
% of portfolio
0.01%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$806 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$628 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$447 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$413 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$360 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.17B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...